Amedeo Smart

Free Medical Literature Service


 

Amedeo

Colorectal Neoplasms

  Free Subscription

Articles published in
Br J Cancer
    September 2017
  1. MATSUMOTO A, Arcaroli J, Chen Y, Gasparetto M, et al
    Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
    Br J Cancer. 2017 Sep 7. doi: 10.1038/bjc.2017.
    >> Share

  2. SCHUBERT SA, Ruano D, Elsayed FA, Boot A, et al
    Evidence for genetic association between chromosome 1q loci and predisposition to colorectal neoplasia.
    Br J Cancer. 2017;117:876-884.
    >> Share

    August 2017
  3. FOWLER H, Belot A, Njagi EN, Luque-Fernandez MA, et al
    Persistent inequalities in 90-day colon cancer mortality: an English cohort study.
    Br J Cancer. 2017 Aug 31. doi: 10.1038/bjc.2017.
    >> Share

  4. LEVI F, Karaboue A, Saffroy R, Desterke C, et al
    Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228).
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    >> Share

  5. YUAN C, Bao Y, Sato K, Nimptsch K, et al
    Influence of dietary insulin scores on survival in colorectal cancer patients.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    >> Share

  6. YANG SS, Li XM, Yang M, Ren XL, et al
    FMNL2 destabilises COMMD10 to activate NF-kappaB pathway in invasion and metastasis of colorectal cancer.
    Br J Cancer. 2017 Aug 17. doi: 10.1038/bjc.2017.
    >> Share

  7. YUAN Z, Baker K, Redman MW, Wang L, et al
    Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
    Br J Cancer. 2017 Aug 15. doi: 10.1038/bjc.2017.
    >> Share

  8. TORRING ML, Murchie P, Hamilton W, Vedsted P, et al
    Evidence of advanced stage colorectal cancer with longer diagnostic intervals: a pooled analysis of seven primary care cohorts comprising 11 720 patients in five countries.
    Br J Cancer. 2017 Aug 8. doi: 10.1038/bjc.2017.
    >> Share

  9. ZHU Y, Wang PP, Zhai G, Bapat B, et al
    Vitamin D receptor and calcium-sensing receptor polymorphisms and colorectal cancer survival in the Newfoundland population.
    Br J Cancer. 2017 Aug 1. doi: 10.1038/bjc.2017.
    >> Share

    July 2017
  10. BHATTACHARYA R, Fan F, Wang R, Ye X, et al
    Intracrine VEGF signalling mediates colorectal cancer cell migration and invasion.
    Br J Cancer. 2017 Jul 25. doi: 10.1038/bjc.2017.
    >> Share

  11. WALKER AK, Kartsonaki C, Collantes E, Nicholson J, et al
    No additional prognostic value for MRE11 in squamous cell carcinomas of the anus treated with chemo-radiotherapy.
    Br J Cancer. 2017;117:322-325.
    >> Share

  12. KNUDSEN MD, Berstad P, Hjartaker A, Gulichsen EH, et al
    Lifestyle predictors for non-participation and outcome in the second round of faecal immunochemical test in colorectal cancer screening.
    Br J Cancer. 2017 Jul 13. doi: 10.1038/bjc.2017.
    >> Share

  13. GASH KJ, Chambers AC, Cotton DE, Williams AC, et al
    Potentiating the effects of radiotherapy in rectal cancer: the role of aspirin, statins and metformin as adjuncts to therapy.
    Br J Cancer. 2017;117:210-219.
    >> Share

  14. ALONSO MH, Ausso S, Lopez-Doriga A, Cordero D, et al
    Comprehensive analysis of copy number aberrations in microsatellite stable colon cancer in view of stromal component.
    Br J Cancer. 2017 Jul 6. doi: 10.1038/bjc.2017.
    >> Share

    June 2017
  15. LIAO Q, Li R, Zhou R, Pan Z, et al
    LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
    Br J Cancer. 2017 Jun 29. doi: 10.1038/bjc.2017.
    >> Share

  16. ODDO D, Siravegna G, Gloghini A, Vernieri C, et al
    Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer.
    Br J Cancer. 2017 Jun 27. doi: 10.1038/bjc.2017.
    >> Share

  17. SAMARENDRA H, Jones K, Petrinic T, Silva MA, et al
    A meta-analysis of CXCL12 expression for cancer prognosis.
    Br J Cancer. 2017;117:124-135.
    >> Share

  18. CHAKRABARTY S, Varghese VK, Sahu P, Jayaram P, et al
    Targeted sequencing-based analyses of candidate gene variants in ulcerative colitis-associated colorectal neoplasia.
    Br J Cancer. 2017;117:136-143.
    >> Share

  19. HATA T, Takemasa I, Takahashi H, Haraguchi N, et al
    Downregulation of serum metabolite GTA-446 as a novel potential marker for early detection of colorectal cancer.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    >> Share

  20. VAN EGGERMOND AM, Schaapveld M, Janus CP, de Boer JP, et al
    Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    >> Share

  21. DEMURTAS L, Puzzoni M, Giampieri R, Ziranu P, et al
    The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab.
    Br J Cancer. 2017 Jun 20. doi: 10.1038/bjc.2017.
    >> Share

  22. MARIANI S, Bertero L, Osella-Abate S, Di Bello C, et al
    Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene.
    Br J Cancer. 2017 Jun 15. doi: 10.1038/bjc.2017.
    >> Share

  23. ALVI MA, Loughrey MB, Dunne P, McQuaid S, et al
    Molecular profiling of signet ring cell colorectal cancer provides a strong rationale for genomic targeted and immune checkpoint inhibitor therapies.
    Br J Cancer. 2017 Jun 8. doi: 10.1038/bjc.2017.
    >> Share

  24. BENTON SC, Butler P, Allen K, Chesters M, et al
    GP participation in increasing uptake in a national bowel cancer screening programme: the PEARL project.
    Br J Cancer. 2017;116:1551-1557.
    >> Share

  25. SIDDIQUI MRS, Simillis C, Hunter C, Chand M, et al
    A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases.
    Br J Cancer. 2017;116:1513-1519.
    >> Share

    May 2017
  26. ALNABULSI A, Swan R, Cash B, Alnabulsi A, et al
    The differential expression of omega-3 and omega-6 fatty acid metabolising enzymes in colorectal cancer and its prognostic significance.
    Br J Cancer. 2017 May 30. doi: 10.1038/bjc.2017.
    >> Share

  27. FREISLING H, Arnold M, Soerjomataram I, O'Doherty MG, et al
    Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe.
    Br J Cancer. 2017;116:1486-1497.
    >> Share

  28. GRAY RT, Loughrey MB, Bankhead P, Cardwell CR, et al
    Statin use, candidate mevalonate pathway biomarkers, and colon cancer survival in a population-based cohort study.
    Br J Cancer. 2017 May 18. doi: 10.1038/bjc.2017.
    >> Share

  29. MOUNCE LTA, Price S, Valderas JM, Hamilton W, et al
    Comorbid conditions delay diagnosis of colorectal cancer: a cohort study using electronic primary care records.
    Br J Cancer. 2017 May 11. doi: 10.1038/bjc.2017.
    >> Share

  30. DYER KE, Dumenci L, Siminoff LA, Thomson MD, et al
    The contribution of body mass index to appraisal delay in colorectal cancer diagnosis: a structural equation modelling study.
    Br J Cancer. 2017 May 2. doi: 10.1038/bjc.2017.
    >> Share

    April 2017
  31. HIRST Y, Skrobanski H, Kerrison RS, Kobayashi LC, et al
    Text-message Reminders in Colorectal Cancer Screening (TRICCS): a randomised controlled trial.
    Br J Cancer. 2017 Apr 25. doi: 10.1038/bjc.2017.
    >> Share

  32. CALEGARI MA, Inno A, Monterisi S, Orlandi A, et al
    A phase 2 study of temozolomide in pretreated metastatic colorectal cancer with MGMT promoter methylation.
    Br J Cancer. 2017 Apr 20. doi: 10.1038/bjc.2017.
    >> Share

  33. PARK JH, van Wyk H, Roxburgh CSD, Horgan PG, et al
    Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
    Br J Cancer. 2017 Apr 20. doi: 10.1038/bjc.2017.
    >> Share

  34. GUREN TK, Thomsen M, Kure EH, Sorbye H, et al
    Cetuximab in treatment of metastatic colorectal cancer: final survival analyses and extended RAS data from the NORDIC-VII study.
    Br J Cancer. 2017 Apr 11. doi: 10.1038/bjc.2017.
    >> Share

  35. YOKOI K, Yamashita K, Ishii S, Tanaka T, et al
    Comprehensive molecular exploration identified promoter DNA methylation of the CRBP1 gene as a determinant of radiation sensitivity in rectal cancer.
    Br J Cancer. 2017;116:1046-1056.
    >> Share

  36. GHUMAN S, Van Hemelrijck M, Garmo H, Holmberg L, et al
    Serum inflammatory markers and colorectal cancer risk and survival.
    Br J Cancer. 2017 Apr 4. doi: 10.1038/bjc.2017.
    >> Share

    March 2017
  37. MALAPELLE U, Mayo de-Las-Casas C, Rocco D, Garzon M, et al
    Development of a gene panel for next-generation sequencing of clinically relevant mutations in cell-free DNA from cancer patients.
    Br J Cancer. 2017;116:802-810.
    >> Share

  38. FURLAN D, Trapani D, Berrino E, Debernardi C, et al
    Oxidative DNA damage induces hypomethylation in a compromised base excision repair colorectal tumourigenesis.
    Br J Cancer. 2017;116:793-801.
    >> Share

  39. BAE JM, Kim JH, Kwak Y, Lee DW, et al
    Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system.
    Br J Cancer. 2017 Mar 9. doi: 10.1038/bjc.2017.
    >> Share

  40. GOSHEN R, Mizrahi B, Akiva P, Kinar Y, et al
    Predicting the presence of colon cancer in members of a health maintenance organisation by evaluating analytes from standard laboratory records.
    Br J Cancer. 2017 Mar 2. doi: 10.1038/bjc.2017.
    >> Share

    February 2017
  41. SCHIFFMANN LM, Brunold M, Liwschitz M, Goede V, et al
    A combination of low-dose bevacizumab and imatinib enhances vascular normalisation without inducing extracellular matrix deposition.
    Br J Cancer. 2017;116:600-608.
    >> Share

  42. JONES RP, Sutton PA, Evans JP, Clifford R, et al
    Specific mutations in KRAS codon 12 are associated with worse overall survival in patients with advanced and recurrent colorectal cancer.
    Br J Cancer. 2017 Feb 16. doi: 10.1038/bjc.2017.
    >> Share

  43. LECLERC D, Pham DN, Levesque N, Truongcao M, et al
    Oncogenic role of PDK4 in human colon cancer cells.
    Br J Cancer. 2017 Feb 16. doi: 10.1038/bjc.2017.
    >> Share

  44. ENGLINGER B, Mair M, Miklos W, Pirker C, et al
    Loss of CUL4A expression is underlying cisplatin hypersensitivity in colorectal carcinoma cells with acquired trabectedin resistance.
    Br J Cancer. 2017;116:489-500.
    >> Share

  45. CARTER JV, Galbraith NJ, Yang D, Burton JF, et al
    Blood-based microRNAs as biomarkers for the diagnosis of colorectal cancer: a systematic review and meta-analysis.
    Br J Cancer. 2017 Feb 2. doi: 10.1038/bjc.2017.
    >> Share

    January 2017
  46. HU H, Shu M, He L, Yu X, et al
    Epigenomic landscape of 5-hydroxymethylcytosine reveals its transcriptional regulation of lncRNAs in colorectal cancer.
    Br J Cancer. 2017 Jan 31. doi: 10.1038/bjc.2016.
    >> Share

  47. CREAVIN B, Ryan E, Martin ST, Hanly A, et al
    Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer.
    Br J Cancer. 2017;116:169-174.
    >> Share

  48. JONES CM, Goh V, Sebag-Montefiore D, Gilbert DC, et al
    Biomarkers in anal cancer: from biological understanding to stratified treatment.
    Br J Cancer. 2017;116:156-162.
    >> Share

  49. MARMORINO F, Salvatore L, Barbara C, Allegrini G, et al
    Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer.
    Br J Cancer. 2017;116:318-323.
    >> Share

  50. AQUINA CT, Mohile SG, Tejani MA, Becerra AZ, et al
    The impact of age on complications, survival, and cause of death following colon cancer surgery.
    Br J Cancer. 2017 Jan 5. doi: 10.1038/bjc.2016.
    >> Share

    December 2016
  51. CRISTOBAL I, Torrejon B, Madoz-Gurpide J, Rojo F, et al
    Comment on 'MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells'.
    Br J Cancer. 2016 Dec 20. doi: 10.1038/bjc.2016.
    >> Share

  52. CHANDRASEKARAN KS, Sathyanarayanan A, Karunagaran D
    Reply: Comment on 'MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells'.
    Br J Cancer. 2016 Dec 20. doi: 10.1038/bjc.2016.
    >> Share

  53. VAN DER VLUGT M, Grobbee EJ, Bossuyt PM, Bongers E, et al
    Adherence to colorectal cancer screening: four rounds of faecal immunochemical test-based screening.
    Br J Cancer. 2016 Dec 6. doi: 10.1038/bjc.2016.
    >> Share

    November 2016
  54. RENNERT G
    Reproductive factors, hormones and colorectal cancer-still unresolved.
    Br J Cancer. 2016 Nov 29. doi: 10.1038/bjc.2016.
    >> Share

  55. MURPHY N, Xu L, Zervoudakis A, Xue X, et al
    Reproductive and menstrual factors and colorectal cancer incidence in the Women's Health Initiative Observational Study.
    Br J Cancer. 2016 Nov 29. doi: 10.1038/bjc.2016.
    >> Share

  56. DE SMEDT L, Palmans S, Andel D, Govaere O, et al
    Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching.
    Br J Cancer. 2016 Nov 24. doi: 10.1038/bjc.2016.
    >> Share

  57. DEN UIL SH, Coupe VM, Linnekamp JF, van den Broek E, et al
    Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.
    Br J Cancer. 2016 Nov 17. doi: 10.1038/bjc.2016.
    >> Share

  58. HE GY, Hu JL, Zhou L, Zhu XH, et al
    The FOXD3/miR-214/MED19 axis suppresses tumour growth and metastasis in human colorectal cancer.
    Br J Cancer. 2016 Nov 3. doi: 10.1038/bjc.2016.
    >> Share

  59. JIA M, Jansen L, Walter V, Tagscherer K, et al
    No association of CpG island methylator phenotype and colorectal cancer survival: population-based study.
    Br J Cancer. 2016 Nov 3. doi: 10.1038/bjc.2016.
    >> Share

    October 2016
  60. MOSKAL A, Freisling H, Byrnes G, Assi N, et al
    Main nutrient patterns and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition study.
    Br J Cancer. 2016 Oct 20. doi: 10.1038/bjc.2016.
    >> Share

  61. KARTHAUS M, Hofheinz RD, Mineur L, Letocha H, et al
    Impact of tumour RAS/BRAF status in a first-line study of panitumumab + FOLFIRI in patients with metastatic colorectal cancer.
    Br J Cancer. 2016 Oct 20. doi: 10.1038/bjc.2016.
    >> Share

  62. BLINMAN P, Mileshkin L, Khaw P, Goss G, et al
    Patients' and clinicians' preferences for adjuvant chemotherapy in endometrial cancer: an ANZGOG substudy of the PORTEC-3 intergroup randomised trial.
    Br J Cancer. 2016 Oct 20. doi: 10.1038/bjc.2016.
    >> Share

  63. KIM TW, Elme A, Kusic Z, Park JO, et al
    A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal cancer.
    Br J Cancer. 2016 Oct 13. doi: 10.1038/bjc.2016.
    >> Share

    September 2016
  64. MARZI L, Combes E, Vie N, Ayrolles-Torro A, et al
    FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
    Br J Cancer. 2016 Sep 29. doi: 10.1038/bjc.2016.
    >> Share

  65. HUANG J, Mondul AM, Weinstein SJ, Koutros S, et al
    Serum metabolomic profiling of prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.
    Br J Cancer. 2016 Sep 27. doi: 10.1038/bjc.2016.
    >> Share

  66. ROGERS AC, Winter DC, Heeney A, Gibbons D, et al
    Systematic review and meta-analysis of the impact of tumour budding in colorectal cancer.
    Br J Cancer. 2016 Sep 6. doi: 10.1038/bjc.2016.
    >> Share

    August 2016
  67. FARSHIDFAR F, Weljie AM, Kopciuk KA, Hilsden R, et al
    A validated metabolomic signature for colorectal cancer: exploration of the clinical value of metabolomics.
    Br J Cancer. 2016 Aug 25. doi: 10.1038/bjc.2016.
    >> Share

  68. RENZI C, Lyratzopoulos G, Card T, Chu TP, et al
    Do colorectal cancer patients diagnosed as an emergency differ from non-emergency patients in their consultation patterns and symptoms? A longitudinal data-linkage study in England.
    Br J Cancer. 2016 Aug 18. doi: 10.1038/bjc.2016.
    >> Share

  69. CHANDRASEKARAN KS, Sathyanarayanan A, Karunagaran D
    MicroRNA-214 suppresses growth, migration and invasion through a novel target, high mobility group AT-hook 1, in human cervical and colorectal cancer cells.
    Br J Cancer. 2016 Aug 18. doi: 10.1038/bjc.2016.
    >> Share

  70. ROSATO V, Guercio V, Bosetti C, Negri E, et al
    Mediterranean diet and colorectal cancer risk: a pooled analysis of three Italian case-control studies.
    Br J Cancer. 2016 Aug 18. doi: 10.1038/bjc.2016.
    >> Share

  71. LIGI D, Mannello F
    Do matrix metalloproteinases represent reliable circulating biomarkers in colorectal cancer?
    Br J Cancer. 2016 Aug 16. doi: 10.1038/bjc.2016.
    >> Share

  72. BEALE G, Haagensen EJ, Thomas HD, Wang LZ, et al
    Combined PI3K and CDK2 inhibition induces cell death and enhances in vivo antitumour activity in colorectal cancer.
    Br J Cancer. 2016 Aug 16. doi: 10.1038/bjc.2016.
    >> Share

  73. WALTER FM, Emery JD, Mendonca S, Hall N, et al
    Symptoms and patient factors associated with longer time to diagnosis for colorectal cancer: results from a prospective cohort study.
    Br J Cancer. 2016 Aug 4. doi: 10.1038/bjc.2016.
    >> Share

    July 2016
  74. DREWES JL, Housseau F, Sears CL
    Sporadic colorectal cancer: microbial contributors to disease prevention, development and therapy.
    Br J Cancer. 2016 Jul 5. doi: 10.1038/bjc.2016.
    >> Share

    June 2016
  75. JARVIS D, Mitchell JS, Law PJ, Palin K, et al
    Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer.
    Br J Cancer. 2016 Jun 23. doi: 10.1038/bjc.2016.
    >> Share

  76. STAFF S, Aaltonen M, Huhtala H, Pylvanainen K, et al
    Endometrial cancer risk factors among Lynch syndrome women: a retrospective cohort study.
    Br J Cancer. 2016 Jun 23. doi: 10.1038/bjc.2016.
    >> Share

  77. PILERI P, Campagnoli S, Grandi A, Parri M, et al
    FAT1: a potential target for monoclonal antibody therapy in colon cancer.
    Br J Cancer. 2016 Jun 21. doi: 10.1038/bjc.2016.
    >> Share

  78. BENITEZ-MAJANO S, Fowler H, Maringe C, Di Girolamo C, et al
    Deriving stage at diagnosis from multiple population-based sources: colorectal and lung cancer in England.
    Br J Cancer. 2016 Jun 21. doi: 10.1038/bjc.2016.
    >> Share

  79. CHA Y, Kim KJ, Han SW, Rhee YY, et al
    Adverse prognostic impact of the CpG island methylator phenotype in metastatic colorectal cancer.
    Br J Cancer. 2016 Jun 16. doi: 10.1038/bjc.2016.
    >> Share

  80. VAN WYK HC, Park JH, Edwards J, Horgan PG, et al
    The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
    Br J Cancer. 2016 Jun 14. doi: 10.1038/bjc.2016.
    >> Share

  81. KONDO T, Okabayashi K, Hasegawa H, Tsuruta M, et al
    The impact of hepatic fibrosis on the incidence of liver metastasis from colorectal cancer.
    Br J Cancer. 2016 Jun 9. doi: 10.1038/bjc.2016.
    >> Share

  82. LEE MS, McGuffey EJ, Morris JS, Manyam G, et al
    Association of CpG island methylator phenotype and EREG/AREG methylation and expression in colorectal cancer.
    Br J Cancer. 2016 Jun 7. doi: 10.1038/bjc.2016.
    >> Share

    May 2016
  83. VAYRYNEN SA, Vayrynen JP, Klintrup K, Makela J, et al
    Clinical impact and network of determinants of tumour necrosis in colorectal cancer.
    Br J Cancer. 2016 May 19. doi: 10.1038/bjc.2016.
    >> Share

    April 2016
  84. JOHNSON SP, Ramasawmy R, Campbell-Washburn AE, Wells JA, et al
    Acute changes in liver tumour perfusion measured non-invasively with arterial spin labelling.
    Br J Cancer. 2016;114:897-904.
    >> Share

    March 2016
  85. POTTEGARD A, Ennis ZN, Hallas J, Jensen BL, et al
    Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case-control study.
    Br J Cancer. 2016;114:571-5.
    >> Share

    February 2016
  86. MAX N, Harbaum L, Pollheimer MJ, Lindtner RA, et al
    Tumour budding with and without admixed inflammation: two different sides of the same coin?
    Br J Cancer. 2016;114:368-71.
    >> Share

  87. LOMAKINA ME, Lallemand F, Vacher S, Molinie N, et al
    Arpin downregulation in breast cancer is associated with poor prognosis.
    Br J Cancer. 2016 Feb 11. doi: 10.1038/bjc.2016.
    >> Share

  88. MARSHALL DC, Webb TE, Hall RA, Salciccioli JD, et al
    Trends in UK regional cancer mortality 1991-2007.
    Br J Cancer. 2016;114:340-7.
    >> Share

  89. KEARNS B, Whyte S, Seaman HE, Snowball J, et al
    Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm.
    Br J Cancer. 2016;114:327-33.
    >> Share

  90. RAINE R, Duffy SW, Wardle J, Solmi F, et al
    Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening.
    Br J Cancer. 2016;114:321-6.
    >> Share

    January 2016
  91. KIM SA, Inamura K, Yamauchi M, Nishihara R, et al
    Loss of CDH1 (E-cadherin) expression is associated with infiltrative tumour growth and lymph node metastasis.
    Br J Cancer. 2016;114:199-206.
    >> Share

  92. GILBERT DC, Serup-Hansen E, Linnemann D, Hogdall E, et al
    Tumour-infiltrating lymphocyte scores effectively stratify outcomes over and above p16 post chemo-radiotherapy in anal cancer.
    Br J Cancer. 2016;114:134-7.
    >> Share

  93. KEUM N, Cao Y, Lee DH, Park SM, et al
    Male pattern baldness and risk of colorectal neoplasia.
    Br J Cancer. 2016;114:110-7.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016